WHO Register of non-State actors

Disclaimer:

Information regarding a non-State actor, contained in the section “Non-State Actors Profiles” in the Register, has been provided by that non-State actor itself, and the accuracy and completeness of such information is the sole responsibility of that non-State actor, not WHO. In turn, information in the sections “WHO’s Engagement” and “Non-State Actors in Official Relations” has been provided by WHO, subject to certain conditions. All access and use of any section of the Register is governed by the Terms and Conditions of Use.

Overview

Official name

International Commission on Non-Ionizing Radiation Protection

Acronym (if applicable)

ICNIRP

Short self description

ICNIRP is a non profit association registered in Germany. ICNIRP provides scientific advice and guidance on the effects of non-ionizing radiation (NIR) to protect people’s health and the environment from detrimental NIR exposure.

Website

http://www.icnirp.org

Web link to health relevant activities

Parent entity (if applicable)

The entity you represent is indicated as a parent of the following entities in the Register:

N / A

Date submitted

09 Nov 2023 05:19:53 PM

General information

Name

Official name

International Commission on Non-Ionizing Radiation Protection

Acronym (if applicable)

ICNIRP

Commonly used name (if applicable)

Names in other official languages (if applicable) Name Abbreviation

International Commission on Non-Ionizing Radiation Protection

ICNIRP

Former name

ICNIRP

Short self description

Address Contact

Address 1

c/o Bundesamt fuer Strahlenschutz, Ingolstaedter Landstr. 1

Address 2

Address 3

Town/City

Oberschleissheim

State/Region

Postal code

85764

Country

Germany

Email (generic)

info@icnirp.org

Related links

Website

http://www.icnirp.org

Governance

Legal status

Non profit association registered in Germany (eingetragener Verein - VR 14570)

Year established

1993

Governance structure

Description of main decision making bodies (e.g. board, board of directors, executive board, executive committee, etc).

Name of body

Executive Board (Vorstand)

Composition and current list of members Name Function Affiliation

Rodney Croft

Chair

Professor, Australian Centre for Electromagnetic Bioeffects Research, University of Wollongong, Australia

Eric van Rongen

Vice Chair

retired, formerly Senior Scientific Staff Member, Health Council, The Netherlands

Gunde Ziegelberger

Scientific Secretary

Head of Working Group on Electromagnetic Fields, Federal Office for Radiation Protection (BfS), Germany

Functions

The Board represents ICNIRP legally and in its relations with external, international and national partners and with the press.

Name of body

Main Commission

Composition and current list of members Name Function Affiliation

Rodney Croft

Chair

Professor of Health Psychology, University of Wollongong, Australia

Eric van Rongen

Vice Chair

Retired in 2023 - Senior Scientific Staff member, Health Council, The Netherlands

Nigel Cridland

Member

Group Leader, Centre for Radiation, Chemical and Environmental Hazards, Public Health England, United Kingdom

Akimasa Hirata

Member

Research Director, Center of Biomedical Physics and Information Technology and Professor, Department of Electrical and Mechanical Engineering, Nagoya Institute of Technology, Japan

Anke Huss

Member

Assistant Professor, Utrecht University, The Netherlands

Guglielmo d'Inzeo

Member

Retired in 2023 - Professor, University of Rome, Italy

Ken Karipidis

Member

Assistant Director, Assessment and Advice Section, Radiation Health Services Branch, Australian Radiation Protection and Nuclear Safety Authority, Australia

Carmela Marino

Member

Retired in 2023 - Director, Division Health Protection Technology, Agency for New Technologies, Energy and Sustainable Economic Development (ENEA), Italy

Sharon Miller

Member

Senior Optical Engineer, Division of Radiological Health Center for Devices and Radiological Health, Food and Drug Administration, USA

Gunnhild Oftedal

Member

Retired in 2023 - Associate Professor, Norwegian University of Science and Technology (NTNU), Norway

Martin Röösli

Member

Professor of Environmental Epidemiology, Swiss Tropical and Public Health Institute, Basel, Switzerland

Soichi Watanabe

Member

Director of Electromagnetic Compatibility Laboratory, Applied Electromagnetic Research Institute, the National Institute of Information and Communications Technology (NICT), Japan

Functions

Formulating and implementing ICNIRP policy in accordance with the Charter and resources available.
Specifying, prioritizing and directing the ICNIRP work plan.
Providing chairmanship and scientific expertise to the Project Groups and coordinating their activities according to the needs of ICNIRP.
Reviewing and approving proposed ICNIRP publications.
Fostering cooperation with other organizations in the field of non-ionizing radiation protection.

General Assembly

Does the entity have a General Assembly of members or a similar body?

Yes

Name

ICNIRP Commission Members

Composition

see above

Functions

The General Assembly meets once a year to discuss and oversee the activities of the Commission and its Board (described above).

Financial information

Latest available annual income (month/year)

From

January

2022

December

2022

Annual income (USD)

153,008

Latest available assets (month/year)

As of

December

2022

Total assets (USD)

Income sources (in USD)

Income source Income type

Private sector entities (including business associations)

Philanthropic foundations

NGOs, academic institutions

Government entities, intergovernmental organizations, including UN

General public, individuals

Total

Sales of goods and services *

459

Grants / Donations

2,990

124,559

127,549

In-kind donations

25,000

Membership fees

Investment income

Others

Total

2,990

149,559

459

153,008

* income from congresses / conferences should be listed under Sales of goods and services

Additional information

In kind donations relate to the ICNIRP office, which is hosted by the German Federal Office for Radiation Protection (corresponding to approx 10000 USD/year) and travel costs' evaluation of the meeting and workshop hosted in Japan by the Nagoya Institute of Technology in 2022 (approx. 15000 USD).

Membership

Entity's members

Is the entity you represent membership based?

Yes

Overview of categories and their voting rights in the main governing body:

Total number Voting

Individuals

NGOs

Private sector entities

Philanthropic foundations

Academic institutions

Government entities

Intergovernmental organizations

Organizational Structure

Parent entity

In the register Registered Entity Entity Name

No data available

Yes

Legal status

Affiliated entities (or subsidiaries)

In the register Registered Entity Entity Name

No data available

Relations

Entity's membership in other entities

In the register Registered Entity Entity Name Type of membership

No data available

Members of the entity

In the register Registered Entity Member Name

No data available

Activities

Aims (or purposes, objectives) of the entity as they appear in its constitution or by-laws or equivalent document.

The Commission is established for the purpose of advancing Non-Ionizing Radiation Protection for the benefit of people and the environment and in particular to provide guidance and recommendations on protection from NIR exposure.
The Commission shall independently develop scientific protection criteria based on science, provide scientific guidance and recommendations on protection from non-ionizing radiation (NIR) exposure, carry out scientific seminars and educational conferences and publish scientific reports on protection against NIR. It shall, inter alia, continue the work previously conducted by the International Non-Ionizing Radiation Committee (INIRC) of the International Radiation Protection Association (IRPA).

The activities of the entity are related to the following strategic priorities and outcomes of the current WHO's General Programme of Work:

Strategic Priority 1: One billion more people benefiting from universal health coverage

Outcome 1.1 - improved access to quality essential health services

Outcome 1.2 - reduced number of people suffering financial hardships

Outcome 1.3 - improved access to essential medicines, vaccines, diagnostics and devices for primary health care

Strategic Priority 2: One billion more people better protected from health emergencies

Outcome 2.1 - countries prepared for health emergencies

Outcome 2.2 - epidemics and pandemics prevented

Outcome 2.3 - health emergencies rapidly detected and responded to

Strategic Priority 3: One billion more people enjoying better health and well-being

Outcome 3.1 - determinants of health addressed

Outcome 3.2 - risk factors reduced through multisectoral action

Outcome 3.3 - healthy settings and Health in All Policies promoted

Strategic Priority 4: More effective and efficient WHO providing better support to countries

Outcome 4.1 - strengthened country capacity in data and innovation

Additional information on the entity's activities

Assessment of health impact and development of exposure levels associated with non-ionizing radiation (WHO 3.1.2)

Country presence

Countries where the entity has activities, members and regional offices / representatives:

Regions

Countries

Activities

Members

Offices / representatives

African Region

Region of the Americas

Eastern Mediterranean Region

European Region

South-East Asia Region

Western Pacific Region

Global

Disclosure & declaration

Tobacco/Arms related disclosure statement for non-State actors

Pursuant the WHO Framework of Engagement with Non-State Actors, WHO does not engage with the tobacco industry or non-State actors that work to further the interests of the tobacco industry. WHO also does not engage with the arms industry.

For the purposes of this statement:

tobacco industry means any entity involved in the manufacture, sale or distribution of tobacco and related products, and any affiliate of such entity; and
arms industry means any entity involved in the manufacture, sale or distribution of arms, and any affiliate of such entity.

This disclosure statement needs to be provided by any nongovernmental organization, private sector entity, philanthropic foundation and academic institution prior to engaging with WHO.

In view of the foregoing, please answer the following questions:

Is your entity, or was your entity over the last four years, part of the tobacco or arms industries (as defined above)?

Yes

No

Unable to answer

To the best of your entity’s knowledge, is your entity, or has your entity over the last four years, engaged in activities that are aimed at furthering or supporting the interests of the tobacco industry? This includes, but is not limited to, supply contracts, contract work, services and lobbying.

Yes

No

Unable to answer

To the best of your entity’s knowledge, does your entity currently, or did your entity over the last four years, have any other association or relationship with the tobacco industry (as defined above). This includes in particular investment interests (other than general mutual funds or similar arrangements whereby your entity has no control over the selection of the investments), commercial business interests, the provision or receipt of financial and/or other support.

Yes

No

Unable to answer

If you have answered yes to any of the above or are unable to answer one or more questions, please provide a general statement of explanation.

Please note that the WHO Secretariat reserves the right to request additional information from your entity in this regard.

By providing this statement, your entity commits to promptly inform WHO of any change to the above information and to complete a new statement that describes the changes.

Engagement with other industries affecting human health or affected by WHO norm and standards

Does the entity you represent have any formal association, affiliation or links with the following industry sectors?

If yes, please tick the box of the industry concerned and provide details in the space provided:

Alcohol

Chemical

Food and beverages

Health care

Pharmaceutical

Others

Please specify industry

WHO Secretariat reserves the right to request additional information from the entity you represent relevant to its engagement with WHO.

*Sexual Exploitation, Abuse and Harassment (SEAH) and Misconduct (abusive or fraudulent)

Entities engaging with WHO are expected to ensure that the conduct of their employees and any other persons engaged by them to perform any activities or to provide any services for WHO on behalf of the entities is consistent with the WHO standards of conduct. In particular, WHO has zero tolerance towards any form of sexual misconduct, which includes sexual exploitation, sexual abuse, sexual violence, and sexual harassment, and other types of abusive or fraudulent conduct. In the view of the forgoing, please confirm that your entity shall:

Take all reasonable and appropriate measures to prevent sexual misconduct as defined in WHO’s Policy on Preventing and Addressing Sexual Misconduct, and other types of abusive or fraudulent conduct as defined, respectively, in WHO’s Policy on Preventing and Addressing Abusive Conduct and in WHO’s Policy on Prevention, Detection and Response to Fraud and Corruption by any of its employees and by any other persons engaged by it to perform any activities or to provide any services for WHO on the entity’s behalf;

Promptly report to WHO’s Office of Internal Oversight Services (IOS) at investigation@who.int any actual or suspected misconduct, as defined by WHO in these Policies and of which the entity becomes aware;

Promptly communicate to IOS any measures that may be necessary or appropriate to protect the confidentiality and wellbeing of the alleged victim;

Promptly respond to any actual or suspected misconduct as defined by WHO in these Policies of which the entity becomes aware; and

To cooperate with IOS and keep IOS informed of the status and outcome of any measures of protection, corrections to operations, investigation, and disciplinary action taken against any perpetrator by the entity.

Date submitted